156
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Muc5ac Production Inhibited by Decreased lncRNA H19 via PI3K/Akt/NF-kB in Asthma

, , , , , , , & show all
Pages 1033-1043 | Published online: 14 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Feng-jia Chen, Li-juan Du, Zhimin Zeng, Xin-yan Huang, Chang-yi Xu, Wei-ping Tan, Can-mao Xie, Yu-xia Liang & Yu-biao Guo. (2022) PTPRH Alleviates Airway Obstruction and Th2 Inflammation in Asthma as a Protective Factor. Journal of Asthma and Allergy 15, pages 133-144.
Read now

Articles from other publishers (4)

Vietdung Nguyen, Qing Zhang, Fei Pan, Qi Jin, Meng Sun, Jakkree Tangthianchaichana, Shouying Du & Yang Lu. (2023) Zi-Su-Zi decoction improves airway hyperresponsiveness in cough-variant asthma rat model through PI3K/AKT1/mTOR, JAK2/STAT3 and HIF-1α/NF-κB signaling pathways. Journal of Ethnopharmacology 314, pages 116637.
Crossref
Hong‐Bo Liu, Juan Bai & Wen‐Xiao Wang. (2022) CST1 promotes the proliferation and migration of PDGF‐BB ‐treated airway smooth muscle cells via the PI3K / AKT signaling pathway . The Kaohsiung Journal of Medical Sciences 39:2, pages 145-153.
Crossref
Shenghao Cheng, Qingping Tang, Shaobing Xie, Sihui Wen, Hua Zhang, Zhihai Xie & Weihong Jiang. (2022) The Role of Noncoding RNA in Airway Allergic Diseases through Regulation of T Cell Subsets. Mediators of Inflammation 2022, pages 1-15.
Crossref
Jinghui Xie, Yuedi Hu, Dengdi Sun, Changan Liu, Zegeng Li & Jie Zhu. (2022) Targeting non-coding RNA H19: A potential therapeutic approach in pulmonary diseases. Frontiers in Pharmacology 13.
Crossref